ResMed (RMD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500, Dow futures muted after big bank earnings, chip slide weighs
- Oil prices ease as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $234.60 --0%
Revenue Growth %: +6.9%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
PGR, OMID, ACI, More
Revenue Growth %: +6.9%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
PGR, OMID, ACI, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson & Johnson (JNJ) Tops Q3 EPS by 6c; adjusts forecast
- Wells Fargo (WFC) Tops Q3 EPS by 3c; misses on revenue, NII
- FB Financial Corporation (FBK) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
